<DOC>
	<DOCNO>NCT01507857</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , immunogenicity safety EV71 Vaccines prevent Hand , Foot Mouth disease cause EV71 total 10,000 healthy infant volunteer age 6 35months old .</brief_summary>
	<brief_title>An Efficacy Trial Inactivated Enterovirus Type 71 ( EV71 ) Vaccine</brief_title>
	<detailed_description>The phase II study inactivate vaccine ( vero cell ) EV71 complete Dec 2011 China . The data phase I II study suggest inactivated EV71 vaccine clinically acceptable safety good immunogenicity healthy Chinese infant . In order evaluate efficacy vaccine Hand , Foot Mouth disease cause EV71 , explore safety profile vaccine expend infant population , phase III clinical trial plan conduct .</detailed_description>
	<mesh_term>Mouth Diseases</mesh_term>
	<mesh_term>Enterovirus Infections</mesh_term>
	<mesh_term>Foot-and-Mouth Disease</mesh_term>
	<mesh_term>Hand , Foot Mouth Disease</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female , age 6 month 11 year old Health determine medical history , physical examination , laboratory examination clinical judgment investigator Provided legal identification sake recruitment Subjects and/or parent ( ) /legal guardian ( ) able understand sign inform consent History Handfootmouth Disease Subject allergic history vaccine , allergic ingredient vaccine Serious adverse reaction vaccine anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain Congenital malformation developmental disorder , genetic defect , severe malnutrition Epilepsy , seizures convulsion history , family history mental illness Autoimmune disease immunodeficiency , parent , brother sister autoimmune disease immunodeficiency History asthma , angioedema , diabetes malignancy History thyroidectomy thyroid disease require medication within past 12 month Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draw Asplenia , functional asplenia condition result absence removal spleen Acute illness acute exacerbation chronic disease within past 7 day Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) History blood product within 3 month Administration live attenuate vaccine within 14 day Administration subunit inactivate vaccine , e.g. , pneumococcal vaccine , allergy treatment within 7 day Axillary temperature &gt; 37.0 centigrade vaccination Abnormal laboratory parameter vaccination Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>EV71 vaccine</keyword>
	<keyword>HFMD</keyword>
	<keyword>efficacy</keyword>
	<keyword>EV71 associate disease</keyword>
</DOC>